Clarisse Lobo

2.1k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

Clarisse Lobo is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Clarisse Lobo has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 17 papers in Hematology and 8 papers in Rheumatology. Recurrent topics in Clarisse Lobo's work include Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (11 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Clarisse Lobo is often cited by papers focused on Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (11 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Clarisse Lobo collaborates with scholars based in Brazil, United States and Italy. Clarisse Lobo's co-authors include Hagop M. Kantarjian, Richard A. Larson, Timothy P. Hughes, Andreas Hochhaus, Giuseppe Saglio, Ricardo Pasqüini, Richard E. Clark, Albert Hoenekopp, Neil J. Gallagher and Md Ariful Haque and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Clarisse Lobo

22 papers receiving 1.5k citations

Hit Papers

Nilotinib versus Imatinib... 2010 2026 2015 2020 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
    2010 1.2k citations Giuseppe Saglio, Dong‐Wook Kim et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clarisse Lobo Brazil 12 1.3k 1.1k 647 195 145 24 1.5k
P. Le Coutre Germany 5 1.3k 1.0× 1.1k 1.0× 673 1.0× 245 1.3× 158 1.1× 5 1.6k
Rick E. Blakesley United States 11 1.1k 0.9× 965 0.9× 625 1.0× 170 0.9× 124 0.9× 24 1.4k
Agnès Guerci‐Bresler France 18 1.4k 1.1× 1.1k 1.0× 546 0.8× 237 1.2× 111 0.8× 53 1.5k
Carolina Pavlovsky Argentina 11 890 0.7× 749 0.7× 456 0.7× 161 0.8× 106 0.7× 36 1.0k
Juan Luis Steegmann Spain 20 1.9k 1.5× 1.6k 1.4× 929 1.4× 329 1.7× 220 1.5× 73 2.3k
Lydia Wunderle Germany 9 1.2k 0.9× 739 0.7× 538 0.8× 262 1.3× 464 3.2× 17 1.5k
Philippe Rousselot France 16 2.0k 1.6× 1.7k 1.5× 1.0k 1.5× 365 1.9× 209 1.4× 31 2.3k
S G O'Brien United Kingdom 10 828 0.6× 685 0.6× 420 0.6× 131 0.7× 87 0.6× 13 976
François-Xavier Mahon France 10 830 0.6× 721 0.6× 368 0.6× 139 0.7× 121 0.8× 11 1.0k
Kasia Kozlowski United Kingdom 11 712 0.5× 670 0.6× 306 0.5× 202 1.0× 134 0.9× 16 1.2k

Countries citing papers authored by Clarisse Lobo

Since Specialization
Citations

This map shows the geographic impact of Clarisse Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarisse Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarisse Lobo more than expected).

Fields of papers citing papers by Clarisse Lobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarisse Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarisse Lobo. The network helps show where Clarisse Lobo may publish in the future.

Co-authorship network of co-authors of Clarisse Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of Clarisse Lobo. A scholar is included among the top collaborators of Clarisse Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarisse Lobo. Clarisse Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nascimento, Emília Matos do, et al.. (2025). Hydroxyurea therapy in sickle cell disease: evaluating health care costs and use in a Brazilian tertiary setting. PubMed. 2(1). 100040–100040.
2.
Nascimento, Emília Matos do, et al.. (2025). Variability in Health Outcomes According to Pediatric to Adult Transfer-of-Care Status Among Young Adults With Sickle Cell Disease. Journal of Adolescent Health. 76(6). 1001–1007.
3.
4.
Cançado, Rodolfo Delfini, Nora Watman, Clarisse Lobo, et al.. (2018). Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study. Hematology. 23(9). 676–682. 11 indexed citations
5.
6.
Lobo, Clarisse, et al.. (2014). Treatment of the acute sickle cell vaso‐occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine. European Journal Of Haematology. 93(1). 34–40. 12 indexed citations
7.
Leite, Ana Claúdia Celestino Bezerra, Raquel de Vasconcellos Carvalhães de Oliveira, Patrícia Moura, Célia Maria Silva, & Clarisse Lobo. (2012). Abnormal transcranial Döppler ultrasonography in children with sickle cell disease. SHILAP Revista de lepidopterología. 34(4). 307–310. 19 indexed citations
8.
9.
Lobo, Clarisse, et al.. (2011). Cognitive Dysfunction Occurs In Children with Sickle Cell Anemia without Cerebral Ischemic Insult or Vasculopathy. Blood. 118(21). 1076–1076. 1 indexed citations
10.
Silva, Danilo Grünig Humberto da, Edis Belini, Lidiane S. Torres, et al.. (2011). Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia. Blood Cells Molecules and Diseases. 47(1). 23–28. 43 indexed citations
11.
12.
Lobo, Clarisse, Jane S. Hankins, Patrícia Moura, & Jorge Francisco da Cunha Pinto. (2010). Hydroxyurea Therapy Reduces Mortality Among Children with Sickle Cell Disease. Blood. 116(21). 843–843. 9 indexed citations
13.
Cançado, Rodolfo Delfini, et al.. (2010). Tratamento da anemia ferropriva com ferro por via parenteral. Revista Brasileira de Hematologia e Hemoterapia. 32. 121–128. 7 indexed citations
14.
Saglio, Giuseppe, Dong‐Wook Kim, Surapol Issaragrisil, et al.. (2010). Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia. New England Journal of Medicine. 362(24). 2251–2259. 1182 indexed citations breakdown →
15.
Cançado, Rodolfo Delfini, et al.. (2010). Tratamento da anemia ferropriva com ferro por via oral. Revista Brasileira de Hematologia e Hemoterapia. 32. 114–120. 15 indexed citations
16.
Hughes, Timothy P., Andreas Hochhaus, Giuseppe Saglio, et al.. (2010). ENESTnd Update: Continued Superiority of Nilotinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP). Blood. 116(21). 207–207. 37 indexed citations
17.
18.
Lobo, Clarisse, et al.. (2008). Consenso brasileiro sobre atividades esportivas e militares e herança falciforme no Brasil - 2007. Revista Brasileira de Hematologia e Hemoterapia. 30(6). 4 indexed citations
19.
Howard, Thad A., et al.. (2008). CHEMICAL AND FUNCTIONAL ANALYSIS OF GENERIC HYDROXYUREA FORMULATIONS. Pediatric Hematology and Oncology. 25(5). 423–429. 6 indexed citations
20.
Ojeda, Edilberto, Jose Ruiz, Ángel Cosme, & Clarisse Lobo. (1997). [Menetrier disease associated with ulcerative colitis. Response to the treatment with octreotide. Review of the diagnostic criteria and etiopathogenesis].. PubMed. 20(4). 175–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Le Coutre Breakdown of academic impact, for papers by Rick E. Blakesley Breakdown of academic impact, for papers by Agnès Guerci‐Bresler Breakdown of academic impact, for papers by Carolina Pavlovsky Breakdown of academic impact, for papers by Juan Luis Steegmann Breakdown of academic impact, for papers by Lydia Wunderle Breakdown of academic impact, for papers by Philippe Rousselot Breakdown of academic impact, for papers by S G O'Brien Breakdown of academic impact, for papers by François-Xavier Mahon Breakdown of academic impact, for papers by Kasia Kozlowski
Rankless by CCL
2026